131 related articles for article (PubMed ID: 11150176)
1. Synthesis and evaluation of isothiocyanate-containing derivatives of the delta-opioid receptor antagonist Tyr-Tic-Phe-Phe (TIPP) as potential affinity labels for delta-opioid receptors.
Maeda DY; Berman F; Murray TF; Aldrich JV
J Med Chem; 2000 Dec; 43(26):5044-9. PubMed ID: 11150176
[TBL] [Abstract][Full Text] [Related]
2. Extended TIP(P) analogues as precursors for labeled delta-opioid receptor ligands.
Kumar V; Murray TF; Aldrich JV
J Med Chem; 2000 Dec; 43(26):5050-4. PubMed ID: 11150177
[TBL] [Abstract][Full Text] [Related]
3. Solid phase synthesis and evaluation of Tyr-Tic-Phe-Phe(p-NHCOCH(2)Br) ([Phe(p-bromoacetamide)(4)]TIPP), a potent affinity label for delta opioid receptors.
Kumar V; Murray TF; Aldrich JV
J Med Chem; 2002 Aug; 45(18):3820-3. PubMed ID: 12190304
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of N,N-dialkyl enkephalin-based affinity labels for delta opioid receptors.
Maeda DY; Ishmael JE; Murray TF; Aldrich JV
J Med Chem; 2000 Oct; 43(21):3941-8. PubMed ID: 11052799
[TBL] [Abstract][Full Text] [Related]
5. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
Ioja E; Tóth G; Benyhe S; Tourwe D; Péter A; Tömböly C; Borsodi A
Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734
[TBL] [Abstract][Full Text] [Related]
6. Dermorphin-based potential affinity labels for mu-opioid receptors.
Choi H; Murray TF; Aldrich JV
J Pept Res; 2003 Jan; 61(1):40-5. PubMed ID: 12472847
[TBL] [Abstract][Full Text] [Related]
7. Dual labeled peptides as tools to study receptors: nanomolar affinity derivatives of TIPP (Tyr-Tic-Phe-Phe) containing an affinity label and biotin as probes of delta opioid receptors.
Aldrich JV; Kumar V; Murray TF; Guang W; Wang JB
Bioconjug Chem; 2009 Feb; 20(2):201-4. PubMed ID: 19175314
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of potential affinity labels derived from endomorphin-2.
Choi H; Murray TF; Aldrich JV
J Pept Res; 2003 Feb; 61(2):58-62. PubMed ID: 12492899
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and binding characteristics of tritiated TIPP[psi], a highly specific and stable delta opioid antagonist.
Nevin ST; Tóth G; Weltrowska G; Schiller PW; Borsodi A
Life Sci; 1995; 56(10):PL225-30. PubMed ID: 7885186
[TBL] [Abstract][Full Text] [Related]
10. A solid-phase synthetic strategy for labeled peptides: synthesis of a biotinylated derivative of the delta opioid receptor antagonist TIPP (Tyr-Tic-Phe-Phe-OH).
Kumar V; Aldrich JV
Org Lett; 2003 Mar; 5(5):613-6. PubMed ID: 12605472
[TBL] [Abstract][Full Text] [Related]
11. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
Weltrowska G; Nguyen TM; Chung NN; Wilkes BC; Schiller PW
Bioorg Med Chem Lett; 2013 Sep; 23(18):5082-5. PubMed ID: 23932788
[TBL] [Abstract][Full Text] [Related]
12. TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity.
Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
J Med Chem; 1993 Oct; 36(21):3182-7. PubMed ID: 8230106
[TBL] [Abstract][Full Text] [Related]
13. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
[TBL] [Abstract][Full Text] [Related]
14. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and binding characteristics of the highly specific, tritiated delta opioid antagonist [3H]TIPP.
Nevin ST; Toth G; Nguyen TM; Schiller PW; Borsodi A
Life Sci; 1993; 53(5):PL57-62. PubMed ID: 8393120
[TBL] [Abstract][Full Text] [Related]
16. [Aladan3]TIPP: a fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity.
Chen H; Chung NN; Lemieux C; Zelent B; Vanderkooi JM; Gryczynski I; Wilkes BC; Schiller PW
Biopolymers; 2005; 80(2-3):325-31. PubMed ID: 15614807
[TBL] [Abstract][Full Text] [Related]
17. An affinity label for delta-opioid receptors derived from [D-Ala2]deltorphin I.
Aldrich JV; Choi H; Murray TF
J Pept Res; 2004 Feb; 63(2):108-15. PubMed ID: 15009532
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive study on the putative δ-opioid receptor (sub)types using the highly selective δ-antagonist, Tyr-Tic-(2S,3R)-β-MePhe-Phe-OH.
Birkas E; Bakota L; Gulya K; Wen T; Pintar J; Tóth G; Szucs M
Neurochem Int; 2011 Aug; 59(2):192-201. PubMed ID: 21672586
[TBL] [Abstract][Full Text] [Related]
19. Novel TIPP (H-Tyr-Tic-Phe-Phe-OH) analogues displaying a wide range of efficacies at the δ opioid receptor. Discovery of two highly potent and selective δ opioid agonists.
Berezowska I; Lemieux C; Chung NN; Ding J; Schiller PW
Bioorg Med Chem Lett; 2012 Mar; 22(5):1899-902. PubMed ID: 22325949
[TBL] [Abstract][Full Text] [Related]
20. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
Schiller PW; Weltrowska G; Berezowska I; Nguyen TM; Wilkes BC; Lemieux C; Chung NN
Biopolymers; 1999; 51(6):411-25. PubMed ID: 10797230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
